{"pmid":32315229,"title":"COVID-19 and the CRISPR Community Response.","text":["COVID-19 and the CRISPR Community Response.","CRISPR J","Davies, Kevin","Barrangou, Rodolphe","32315229"],"journal":"CRISPR J","authors":["Davies, Kevin","Barrangou, Rodolphe"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315229","week":"202017|Apr 20 - Apr 26","doi":"10.1089/crispr.2020.29092.rba","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520056037377,"score":8.518259,"similar":[{"pmid":32300245,"title":"CRISPR-Cas12-based detection of SARS-CoV-2.","text":["CRISPR-Cas12-based detection of SARS-CoV-2.","An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 infection, rapidly spread to produce a global pandemic. We report development of a rapid (<40 min), easy-to-implement and accurate CRISPR-Cas12-based lateral flow assay for detection of SARS-CoV-2 from respiratory swab RNA extracts. We validated our method using contrived reference samples and clinical samples from patients in the United States, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections. Our CRISPR-based DETECTR assay provides a visual and faster alternative to the US Centers for Disease Control and Prevention SARS-CoV-2 real-time RT-PCR assay, with 95% positive predictive agreement and 100% negative predictive agreement.","Nat Biotechnol","Broughton, James P","Deng, Xianding","Yu, Guixia","Fasching, Clare L","Servellita, Venice","Singh, Jasmeet","Miao, Xin","Streithorst, Jessica A","Granados, Andrea","Sotomayor-Gonzalez, Alicia","Zorn, Kelsey","Gopez, Allan","Hsu, Elaine","Gu, Wei","Miller, Steve","Pan, Chao-Yang","Guevara, Hugo","Wadford, Debra A","Chen, Janice S","Chiu, Charles Y","32300245"],"abstract":["An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 infection, rapidly spread to produce a global pandemic. We report development of a rapid (<40 min), easy-to-implement and accurate CRISPR-Cas12-based lateral flow assay for detection of SARS-CoV-2 from respiratory swab RNA extracts. We validated our method using contrived reference samples and clinical samples from patients in the United States, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections. Our CRISPR-based DETECTR assay provides a visual and faster alternative to the US Centers for Disease Control and Prevention SARS-CoV-2 real-time RT-PCR assay, with 95% positive predictive agreement and 100% negative predictive agreement."],"journal":"Nat Biotechnol","authors":["Broughton, James P","Deng, Xianding","Yu, Guixia","Fasching, Clare L","Servellita, Venice","Singh, Jasmeet","Miao, Xin","Streithorst, Jessica A","Granados, Andrea","Sotomayor-Gonzalez, Alicia","Zorn, Kelsey","Gopez, Allan","Hsu, Elaine","Gu, Wei","Miller, Steve","Pan, Chao-Yang","Guevara, Hugo","Wadford, Debra A","Chen, Janice S","Chiu, Charles Y"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32300245","week":"202016|Apr 13 - Apr 19","doi":"10.1038/s41587-020-0513-4","source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","China","United States"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"_version_":1664635401226158080,"score":64.25603},{"pmid":32307095,"title":"Response to COVID-19 by the surgical community.","text":["Response to COVID-19 by the surgical community.","Surgery","Elster, Eric","Potter, Benjamin K","Chung, Kevin","32307095"],"journal":"Surgery","authors":["Elster, Eric","Potter, Benjamin K","Chung, Kevin"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32307095","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.surg.2020.03.011","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664632501395521536,"score":41.344955}]}